Smartphone-Colorimetric Biosensor for Uric Acid through Morphological Transition of Silver Nanoplates
Source abstract
Abstract
Elevated uric acid (UA) serves as a critical biomarker for hyperuricemia-related disorders, yet conventional detection faces cost and complexity limitations. Here, we developed an enzyme-free smartphone-colorimetric biosensor using silver triangular nanoplates (AgTNPs). These anisotropic nanostructures exhibit morphology-dependent surface plasmon resonance (SPR), enabling UA-selective etching that induces a blue-to-yellow color shift. Spectrophotometry revealed a linear response (40–110 μM, R 2 > 0.992) correlating with blue shifts. Smartphone-based green-channel analysis achieved comparable accuracy (R 2 = 0.98) in a 96-well plate. Transmission electron microscopy confirmed UA-driven morphological evolution from triangular to spherical nanoparticles via anisotropic etching. This dual-mode platform provides a cost-effective solution for point-of-care UA monitoring.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gout, Hyperuricemia, Uric Acid · Inflammasome and immune disorders · Streptococcal Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Advanced Technology for Materials Synthesis and Processing
Wuhan University of Technology
Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases, School of Chemistry, Chemical Engineering and Life Science
General Hospital of Central Theater Command
Funding
National Ten Thousand Talent Program · National Natural Science Foundation of China · Youth Top Talent Project of Hubei Provence of China
References (27)
Show source-provided references
1. 10.1038/nature0451610.1038/nature04516 ↗
2. 10.1056/NEJMra080088510.1056/NEJMra0800885 ↗
3. 10.1097/01.ASN.0000034910.58454.FD10.1097/01.ASN.0000034910.58454.FD ↗
4. 10.1016/j.ecoenv.2023.11452510.1016/j.ecoenv.2023.114525 ↗
5. 10.1016/j.pharmthera.2024.10861510.1016/j.pharmthera.2024.108615 ↗
6. 10.1093/clinchem/26.2.22710.1093/clinchem/26.2.227 ↗
7. 10.1016/j.talanta.2003.10.05110.1016/j.talanta.2003.10.051 ↗
8. 10.1021/acs.analchem.6b0458810.1021/acs.analchem.6b04588 ↗
9. 10.1007/s40820-020-00536-910.1007/s40820-020-00536-9 ↗
10. 10.1007/s42114-021-00391-110.1007/s42114-021-00391-1 ↗
11. 10.1002/sstr.20240003410.1002/sstr.202400034 ↗
12. 10.1021/acsami.1c1797410.1021/acsami.1c17974 ↗
13. 10.1021/acsanm.3c0225810.1021/acsanm.3c02258 ↗
14. 10.1039/C4NR03309D10.1039/C4NR03309D ↗
15. 10.1002/idm2.1206910.1002/idm2.12069 ↗
16. 10.1021/acs.langmuir.7b0136210.1021/acs.langmuir.7b01362 ↗
17. 10.1021/ac303591n10.1021/ac303591n ↗
18. 10.1021/acsami.1c1702810.1021/acsami.1c17028 ↗
19. 10.1016/j.saa.2023.12356210.1016/j.saa.2023.123562 ↗
20. 10.1016/j.snb.2019.12704510.1016/j.snb.2019.127045 ↗
21. 10.1134/S106193482460541310.1134/S1061934824605413 ↗
22. 10.1016/j.molliq.2020.11323810.1016/j.molliq.2020.113238 ↗
23. 10.1016/j.snb.2021.13030410.1016/j.snb.2021.130304 ↗
24. 10.3390/s2203084310.3390/s22030843 ↗
25. 10.1016/j.talanta.2016.08.00810.1016/j.talanta.2016.08.008 ↗
26. 10.1116/1.124777710.1116/1.1247777 ↗
27. 10.1088/0031-8949/2/1-2/01410.1088/0031-8949/2/1-2/014 ↗